New therapeutic targets and drugs for the treatment of chronic hepatitis B.

Fletcher SP, Delaney WE. New therapeutic targets and drugs for the treatment of chronic hepatitis B. Semin Liver Dis. 2013 May; 33(2):130-7.

View in: PubMed

subject areas

Animals
Antiviral Agents
Biomarkers
DNA, Viral
Drug Design
Drug Resistance, Viral
Hepatitis B Surface Antigens
Hepatitis B virus
Hepatitis B, Chronic
Humans
Immunologic Factors
Treatment Outcome
Viral Load

authors with profiles

William Delaney

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement